Insights

Innovative Technology Use Evolva leverages advanced fermentation and biotechnology platforms to develop natural, sustainable ingredients that address sourcing bottlenecks, presenting opportunities to collaborate with companies seeking innovative, environmentally-friendly ingredients for health, wellness, and flavor applications.

Expanding Market Footprint Recent product launches such as Veri-teTM Resveratrol for pet supplements and collaborations in bio-fertilizer development indicate growth in both human and animal health markets, suggesting potential sales channels in nutritional supplements, functional foods, and sustainable agriculture sectors.

Recent Asset Sales Evolva's strategic sale of assets to companies like Lallemand and Danstar Ferment signifies a shift towards focused commercial activities, opening avenues for partnership or licensing opportunities in the specialty biotech and fermentation ingredient markets.

Funding & Revenue Growth With revenue estimates between 1 million and 10 million dollars and recent grant inflows, Evolva is positioned for further product development and commercialization, offering prospects for collaborations or investment in emerging biotechnologies and specialty ingredients.

Diverse Application Development Evolva’s focus on developing ingredients for multiple markets including pet care, health supplements, and agricultural solutions highlights opportunities to position products across various health-conscious and sustainability-driven consumer segments.

Evolva Tech Stack

Evolva uses 8 technology products and services including jsDelivr, WordPress, Open Graph, and more. Explore Evolva's tech stack below.

  • jsDelivr
    Content Delivery Network
  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • MySQL
    Database
  • jQuery
    Javascript Libraries
  • The SEO Framework
    Search Engines
  • Google Tag Manager
    Tag Management
  • ShareThis
    Widgets

Media & News

Evolva's Email Address Formats

Evolva uses at least 1 format(s):
Evolva Email FormatsExamplePercentage
FirstL@evolva.comJohnD@evolva.com
86%
FirstLast@evolva.comJohnDoe@evolva.com
6%
FirstML@evolva.comJohnMD@evolva.com
5%
FirstLa@evolva.comJohnDo@evolva.com
3%

Frequently Asked Questions

What is Evolva's phone number?

Minus sign iconPlus sign icon
You can contact Evolva's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evolva's stock symbol?

Minus sign iconPlus sign icon
Evolva is a publicly traded company; the company's stock symbol is ELVAY.

What is Evolva's official website and social media links?

Minus sign iconPlus sign icon
Evolva's official website is evolva.com and has social profiles on LinkedInCrunchbase.

What is Evolva's SIC code NAICS code?

Minus sign iconPlus sign icon
Evolva's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evolva have currently?

Minus sign iconPlus sign icon
As of December 2025, Evolva has approximately 72 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Cmo: N. B.Vice President Regulatory Affairs: J. M.Head Of Business Finance: M. H.. Explore Evolva's employee directory with LeadIQ.

What industry does Evolva belong to?

Minus sign iconPlus sign icon
Evolva operates in the Biotechnology Research industry.

What technology does Evolva use?

Minus sign iconPlus sign icon
Evolva's tech stack includes jsDelivrWordPressOpen GraphMySQLjQueryThe SEO FrameworkGoogle Tag ManagerShareThis.

What is Evolva's email format?

Minus sign iconPlus sign icon
Evolva's email format typically follows the pattern of FirstL@evolva.com. Find more Evolva email formats with LeadIQ.

How much funding has Evolva raised to date?

Minus sign iconPlus sign icon
As of December 2025, Evolva has raised $540K in funding. The last funding round occurred on Oct 21, 2022 for $540K.

Evolva

Biotechnology ResearchBasel-landschaft, Switzerland51-200 Employees

At Evolva we believe in applying technology platforms, such as fermentation, to help resolve sourcing bottlenecks in nature. These enable us to provide products that can contribute to health, wellbeing and sensory enjoyment. We research, develop and commercialize high quality, affordable, ready-to-formulate ingredients that are based on nature and are available at all times, in any quantity. With around 55 employees from 15 nationalities we promote an interdisciplinary and inclusive working environment.

Section iconCompany Overview

Phone number
Website
evolva.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ELVAY
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $540K

    Evolva has raised a total of $540K of funding over 10 rounds. Their latest funding round was raised on Oct 21, 2022 in the amount of $540K.

  • $1M$10M

    Evolva's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $540K

    Evolva has raised a total of $540K of funding over 10 rounds. Their latest funding round was raised on Oct 21, 2022 in the amount of $540K.

  • $1M$10M

    Evolva's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.